Anand Kiran Parikh bought $55k of FTH
President and CEO at Sensei Biotherapeutics, Inc.. 2,806 shares at an average of $19.76, traded Jun 22, 2026, filed Jun 24, 2026.
Score components
- +25RoleCEO
- +7Trade size$55k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- +8Price context34% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002111813-26-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | POpen-market purchase Common Stock | +2,806 | $19.76 | $55k | 764,234 | Jun 24, 2026 |
| Jun 22, 2026 | MOption exercise Common Stock | +45,252 | $1.16 | $52k | 809,486 | Jun 24, 2026 |
| Jun 22, 2026 | MOption exercise Common Stock | +8,213 | $1.16 | $9,527 | 817,699 | Jun 24, 2026 |
| Jun 22, 2026 | MOption exercise Employee Stock Option (right to buy)derivative | -45,252 | $0.00 | $0 | 91,632 | Jun 24, 2026 |
| Jun 22, 2026 | MOption exercise Employee Stock Option (right to buy)derivative | -8,213 | $0.00 | $0 | 4,107 | Jun 24, 2026 |
Related signals
Other insiders at Sensei Biotherapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 64Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $326k 13,634 shares | +41% | |
| 69Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $401k 15,641 shares | +90% | |
| 62Notable | Sensei Biotherapeutics, Inc. | Brian C Stephenson Chief Financial Officer | $406k 17,413 shares | - | |
| 43Moderate | Sensei Biotherapeutics, Inc. | Cambrian BioPharma Inc owner | $501k 25,000 shares | -16% | |
| 43Moderate | Sensei Biotherapeutics, Inc. | James Peyer owner, other | $501k 25,000 shares | -16% | |
| 39Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $818k 30,585 shares | +23% | |
| 21Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $89k 3,250 shares | -2% | |
| 31Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $382k 12,180 shares | +8% | |
| 20Weak | FTHsell Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $77k 2,741 shares | -2% | |
| 23Weak | FTHbuy Sensei Biotherapeutics, Inc. | Millennium Management LLC owner | $141k 4,215 shares | +3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.